Goodman Advisory Group’s Cyclerion Therapeutics CYCN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18	Closed	–	–	164
2022 Q4	$0	Hold	18	–	–	﹤0.01%	147
2022 Q3	$0	Buy	+18	New	–	﹤0.01%	159